Inventor
KING-UNDERWOOD JOHN
GB41 patents
⚠️ This page may combine multiple inventors who share the name “KING-UNDERWOOD JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RESPIVERT LTD
29 patentsUS9108950B2Aug 18, 2015
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors
RESPIVERT LTD38 citations96
US9624196B2Apr 18, 2017
Inhibitor of p38 MAP kinase
RESPIVERT LTD15 citations92
US9475796B2Oct 25, 2016
1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors
RESPIVERT LTD12 citations92
US9447076B2Sep 20, 2016
Inhibitor of p38 map kinase
RESPIVERT LTD16 citations92
US8975285B2Mar 10, 2015
P38 MAP kinase inhibitors
RESPIVERT LTD26 citations92
US9249125B2Feb 2, 2016
Pyrazole derivatives as p38 MAP inhibitors
RESPIVERT LTD30 citations91
US9724347B2Aug 8, 2017
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors
RESPIVERT LTD5 citations84
US9242960B2Jan 26, 2016
P38MAP kinase inhibitors
RESPIVERT LTD6 citations83
US10266519B2Apr 23, 2019
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors
RESPIVERT LTD6 citations82
US9850231B2Dec 26, 2017
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors
RESPIVERT LTD5 citations82
US9701670B2Jul 11, 2017
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD10 citations80
US10238658B2Mar 26, 2019
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors
RESPIVERT LTD3 citations73
US9993478B2Jun 12, 2018
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
RESPIVERT LTD2 citations73
US10294216B2May 21, 2019
Pyrazolyl ureas as kinase inhibitors
RESPIVERT LTD1 citations72
US10738032B2Aug 11, 2020
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitors
RESPIVERT LTD3 citations71
US11634406B2Apr 25, 2023
Inhibitor of p38 MAP kinase
RESPIVERT LTD0 citations62
US9340545B2May 17, 2016
Quinazolin-4 (3H)—one derivatives used as P13 kinase inhibitors
RESPIVERT LTD1 citations62
US9321773B2Apr 26, 2016
Compounds
RESPIVERT LTD2 citations62
US11142515B2Oct 12, 2021
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD0 citations61
US9884845B2Feb 6, 2018
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD1 citations61
US10813932B2Oct 27, 2020
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
RESPIVERT LTD0 citations52
US10815217B2Oct 27, 2020
Inhibitor of p38 MAP kinase
RESPIVERT LTD0 citations51
US10045980B2Aug 14, 2018
Inhibitor of p38 map kinase
RESPIVERT LTD0 citations51
US10028959B2Jul 24, 2018
Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitors
RESPIVERT LTD0 citations51
US10000471B2Jun 19, 2018
Pyrazole P38 map kinase inhibitors
RESPIVERT LTD0 citations51
US9834560B2Dec 5, 2017
Compounds
RESPIVERT LTD1 citations51
US9771354B2Sep 26, 2017
Pyrazole p38 map kinase inhibitors
RESPIVERT LTD1 citations51
US9637494B2May 2, 2017
Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitors
RESPIVERT LTD0 citations51
US10144721B2Dec 4, 2018
P38 MAP kinase inhibitors
RESPIVERT LTD0 citations50
ITO KAZUHIRO
6 patentsUS8642773B2Feb 4, 2014
P38MAP kinase inhibitor
ITO KAZUHIRO44 citations97
US8618140B2Dec 31, 2013
P38 MAP kinase inhibitors
ITO KAZUHIRO41 citations97
US8299073B2Oct 30, 2012
P38 MAP kinase inhibitors
ITO KAZUHIRO50 citations97
US8299074B2Oct 30, 2012
P38 MAP kinase inhibitors
ITO KAZUHIRO48 citations97
US8293748B2Oct 23, 2012
p38 MAP kinase inhibitors
ITO KAZUHIRO47 citations97
US8293771B2Oct 23, 2012
p38 MAP kinase inhibitors
ITO KAZUHIRO49 citations97